Daniel E. Lehane
- Hematology top 2%
- Blood groups and transfusion 9
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 4
- Lung Cancer Research Studies 4
- Genetics top 5%
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies 6
- Immunology top 10%
-
- Erythrocyte Function and Pathophysiology 3
-
- Neonatal Health and Biochemistry 3
-
- Neuroendocrine Tumor Research Advances 3
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- R. B. McConnellP. M. SheppardCyril ClarkeR. FinnW. T. A. DonohoeW. KulkeRobert B. LivingstonJ. C. Woodrow
- Cited by
- HematologyOncologyGenetics
- Partner nations
- United StatesUnited KingdomNigeria
In The Last Decade
Daniel E. Lehane
49 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 114
- Hematology 445
- Oncology 596
- Genetics 166
- Otorhinolaryngology 64
- Immunology 221
Countries citing papers authored by Daniel E. Lehane
This map shows the geographic impact of Daniel E. Lehane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Lehane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Lehane more than expected).
Fields of papers citing papers by Daniel E. Lehane
This network shows the impact of papers produced by Daniel E. Lehane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Lehane. The network helps show where Daniel E. Lehane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel E. Lehane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 6 | |
| 2 | 2011 | 6 | |
| 3 | 1994 | 23 | |
| 4 | 1983 | 51 | |
| 5 | High-dose chlorozotocin in lung cancer: a Southwest Oncology Group Phase II Study. | 1983 | 3 |
| 6 | 1982 | 1 | |
| 7 | 1982 | 41 | |
| 8 | 1981 | 11 | |
| 9 | 1981 | 105 | |
| 10 | 1979 | 47 | |
| 11 | Chemotherapy of disseminated germinal tumors of the testis--comparison of vinblastine and bleomycin with vincristine, bleomycin, and actinomycin D. | 1978 | 8 |
| 12 | The effects of bleomycin on immunocompetence in man. | 1975 | 20 |
| 13 | Adriamycin (NSC-123127) plus 5-fluorouracil (NSC-19893): a phase I study. | 1975 | 1 |
| 14 | 1975 | 42 | |
| 15 | 1975 | 1 | |
| 16 | Immunocompetence of head and neck cancer patients receiving methotrexate (MTX) by two different schedules | 1974 | 2 |
| 17 | 1966 | 5 | |
| 18 | 1964 | 1 | |
| 19 | 1963 | 153 | |
| 20 | 1953 | 71 |
About Daniel E. Lehane
Daniel E. Lehane is a scholar working on Otorhinolaryngology, Hematology, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Blood groups and transfusion (9 papers), Head and Neck Cancer Studies (6 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Research Studies (4 papers), Erythrocyte Function and Pathophysiology (3 papers), Neonatal Health and Biochemistry (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Hematology (445 citations), Oncology (596 citations), Genetics (166 citations), Otorhinolaryngology (64 citations) and Immunology (221 citations). Daniel E. Lehane has collaborated with scholars based in United States, United Kingdom and Nigeria. Frequent co-authors include R. B. McConnell, P. M. Sheppard, Cyril Clarke, R. Finn, W. T. A. Donohoe, W. Kulke, Robert B. Livingston, J. C. Woodrow, R Bottomley and Lance K. Heilbrun. Their work appears in journals such as Cancer, JAMA, The American Journal of Medicine, Nature and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.